Skip to main content

Brevan Howard Capital Management LP

Position in LLY — ELI LILLY & Co

CIK 1512857 ST. HELIER, Y9

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$92,468,863
+$76,723,322 QoQ
Shares Held
77,094
+350.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.67%
of 13F equity value
Holder Rank
#399
of 4,605 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Dec 31, 2025
CallValue
$21,493,602
CallShares
20,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $180,596,811 across 9 Drug Manufacturers - General names. LLY ranks #1 (51.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
This page
77,094 $92,468,863

All Filings in LLY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $92,468,863 77,094
2026-03-31 $15,745,541 17,119
2025-12-31 $19,948,211 18,562
2025-12-31 $21,493,602 20,000
2025-09-30 $15,688,043 20,561
2025-06-30 $15,727,797 20,176
2025-03-31 $1,204,176 1,458
2024-12-31 $18,091,820 23,435
2024-09-30 $27,264,803 30,775
2024-06-30 $508,823 562
2023-12-31 $2,356,162 4,042